Cyclica has officially been acquired by Recursion! If you’ve been following us and believe in our mission, follow Recursion's accounts below to join us as we industrialize #drugdiscovery as one team. ✅ Follow Recursion on LinkedIn ✅ Follow on Twitter @RecursionPharma - https://bit.ly/436tpNn ✅ Subscribe to the @RecursionPharma YouTube channel - https://bit.ly/3C22CWL Help spread the word and share this post with your followers/networks! #techbio #SocialMedia #SocialChannels #biotech #pharma
Cyclica (acquired by Recursion, Nasdaq: RXRX)
Biotechnology Research
Toronto, Ontario 12,754 followers
From molecule to medicine Unlocking the protein universe to discover the medicines of tomorrow
About us
Cyclica has been acquired by Recursion! Please follow @Recursion on LinkedIn and @RecursionPharma on Twitter to receive updates on our next chapter.
- Website
-
https://beacons.ai/cyclica
External link for Cyclica (acquired by Recursion, Nasdaq: RXRX)
- Industry
- Biotechnology Research
- Company size
- 51-200 employees
- Headquarters
- Toronto, Ontario
- Type
- Privately Held
- Founded
- 2013
- Specialties
- Drug Development, Network Pharmacology, Drug Repositioning, Proteomics, Clinical Trials, Side Effects, Bioinformatics, Systems Biology, Drug Discovery, Artificial Intelligence, polypharmacology, medicines, Machine learning, pharmacology, pharmaceuticals, and bioinformatics
Locations
-
Primary
207 Queens Quay W
Toronto, Ontario M5J1A7, CA